Rösler wants to protect the pharmaceutical lobby



We are searching data for your request:

Forums and discussions:
Manuals and reference books:
Data from registers:
Wait the end of the search in all databases.
Upon completion, a link will appear to access the found materials.

Healthcare reform: Rösler wants to protect the pharmaceutical lobby.

(06.09.2010) The original statements by the Federal Minister of Health Philip Rösler on the reform of the health system made hard cuts expected for the pharmaceutical manufacturers as well. But now at least the pharmaceutical importers are spared in the savings plans, like the "Süddeutsche Zeitung" on Saturday, citing a letter from the Federal Ministry of Health to prepare the meeting of health experts from the CDU / CSU and FDP.

Since the importers of cheap medicines should not be negatively affected by the reform of the health system, the higher compulsory discounts of the health insurance companies will not apply to them according to the proposal of the Minister of Health. Only a six percent compulsory discount applies instead of 16 percent as with the German pharmaceutical manufacturers.

Since it became known that the pharmaceutical industry should also contribute to reform, the Association of Pharmaceutical Importers (VAD) has protested vehemently against the planned increase in the compulsory discount. According to the association, around 80 percent of the approx. 40 pharmaceutical importers would have to close when the higher mandatory discount was introduced, which would endanger more than 4,000 jobs.

The pressure had an effect and so the letter that has now become known no longer provides for a corresponding increase in the compulsory discounts for pharmaceutical importers. However, according to the "Süddeutsche Tageszeitung", the Ministry of Health plans to let the importers make their contribution to costs in another way. Pharmacies that have previously imported pharmaceuticals were only given preferential treatment if the savings were at least 15 percent or EUR 15. In the future, the savings should amount to at least 15 percent or EUR 60, which would reduce costs to a similar extent as with an increased mandatory discount.

The pharmaceutical importers use price differences on the European market and buy cheap pharmaceuticals abroad, for example, which they can then sell in Germany. The higher the price difference, the greater the profit. (fp)

Author and source information



Video: Forensic Science: Last Week Tonight with John Oliver HBO


Previous Article

Environmentalists: BPA ban completely inadequate

Next Article

DAK joins forces with BKK Gesundheit